Haemonetics’ $435 Million Convertible Notes Offering

Latham & Watkins LLP represented the initial purchasers in the offering.Haemonetics Corporation (NYSE: HAE) priced its offering of US$435 million aggregate principal amount of 0% Convertible Senior…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now